69
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study

, , , , &
Pages 7-12 | Published online: 05 Feb 2015

References

  • BlackDARoseGBrewerDBControlled trial of prednisone in adult patients with the nephrotic syndromeBr Med J197034214264916790
  • CattranDCDelmoreTRoscoeJA randomized controlled trial of prednisone in patients with idiopathic membranous nephropathyN Engl J Med19893202102152643046
  • [No authors listed]A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study Of The Adult Idiopathic Nephrotic SyndromeN Engl J Med197930113011306388220
  • ChenYSchieppatiACaiGImmunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trialsClin J Am Soc Nephrol2013878779623449768
  • PonticelliCZucchelliPPasseriniPA randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathyN Engl J Med19893208132642605
  • PonticelliCZucchelliPPasseriniPA 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathyKidney Int199548160016048544420
  • LindskogAEbeforsKJohanssonMEMelanocortin 1 receptor agonists reduce proteinuriaJ Am Soc Nephrol2010211290129820507942
  • GongRDworkinLDACTH (Acthar gel) prevents proteinuria and renal injury in the remnant kidney: evidence for direct podocyte protectionJ Am Soc Nephrol201021548A20299354
  • GongRThe renaissance of corticotropin therapy in proteinuric nephropathiesNat Rev Nephrol2011812212822143333
  • LausonHDFormanCWMcNamaraHMattarGBarnettHLThe effect of corticotropin (ACTH) on glomerular permeability to albumin in children with the nephrotic syndromeJ Clin Invest19543365766413152205
  • CameronJSNephrotic syndromeBr Med J197043503535472808
  • [No authors listed]Treatment of nephrotic syndromeBr Med J1970358594316980
  • CoppoRNon-steroidal and non cytotoxic therapies for nephritic syndromeNephrol Dial Transplant2008231793179618441003
  • BergALNilsson-EhlePArnadottirMBeneficial effects of ACTH on serum lipoprotein profile and glomerular function in patients with membranous nephropathyKidney Int1999561534154310504505
  • BergALArnadottirMACTH-induced improvement in nephritic syndrome in patients with a variety of diagnosesNephrol Dial Transplant2004191305130715102969
  • BergALRafnssonATJohannssonMDallongevilleJArnadottirMThe effects of adrenocorticotrophic hormone and equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteinsMetabolism2006551083108716839845
  • RauenTMichealisAFleogeJMertensPRCase series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1–24Clin Nephrol20097163764219473632
  • BombackASCanettaPABeckLHJrAyalonRRadhakrishnanJAppelGBTreatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trialAm J Nephrol201236586722722778
  • TumulinJAGalphinCMRovinBHAdvanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1J Diabetes Res2013201348986924159603
  • HladunewichMACattranDBeckLHA pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (HP Acthar® gel) in nephrotic syndrome due to idiopathic membranous nephropathyNephrol Dial Transplant2014291570157724714414
  • Beloff-ChainAMortonJDunmoreSTaylorGWMorrisHREvidence that the insulin secretagogue, beta-cell-tropin, is ACTH 22–39Nature19833012552586296695
  • PonticelliCPasseriniPSalvadoriMA randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathyAm J Kidney Dis20064723324016431252
  • KDIGO Clinical practice guideline for glomerulonephritisKidney Int Suppl (2011)2012213927425028634
  • BombackASTumulinJABaranskiJTreatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gelDrug Des Devel Ther20115147153
  • HoganJBombackASMehtaKTreatment of idiopathic FSGS with adrenocorticotropic hormone gelClin J Am Soc Nephrol201382072208124009220
  • GongRLeveraging melanocortin pathways to treat glomerular diseasesAdv Chronic Kidney Dis20142113415124602463
  • GongRThe renaissance of corticotropin therapy in proteinuric nephropathiesNat Rev Nephrol2012812212822143333
  • GhiggeriGMBruschiMCandianoGDepletion of clusterin in renal diseases causing nephrotic syndromeKidney Int2002622184219412427144
  • BrzoskaTLugerTAMaaserCAbelsCBöhmMAlfa-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseasesEndocr Rev20082958160218612139
  • SiJGeYZhuangSWangLJChenSGongRAdrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanismsKidney Int20138363564623325074